Monday, 19 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Latest announcements

Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.

19:00 IST BSE
Results UpdateViyash Scientific Ltd VIYASH

Viyash Scientific Results Update

Viyash Scientific reported FY26 revenues of ₹3,420.3 Crore, with PAT growing 1324%. Strong Q4 performance and merger synergies indicate a solid foundation for future growth.

Value
₹3,420 Cr
18:58 IST BSE
Merger & RestructuringGabriel India Ltd GABRIEL

Gabriel India Merger & Restructuring

Gabriel India received the certified NCLT order sanctioning its composite scheme of arrangement. The restructuring involves demerging automotive undertakings into the company to streamline operations.

18:58 IST BSE
DividendHatsun Agro Products Ltd HATSUN

Hatsun Agro Products Dividend

Hatsun Agro Product declared a Rs.10.00 first interim dividend for FY 2026-27. Shareholders recorded by May 26 will receive payment by June 17.

Execution
on or before 17th June 2026
18:54 IST BSE
Results UpdateRites Ltd RITES

Rites Results Update

RITES reported FY26 revenue of ₹2525 Crore and PAT of ₹454 Crore. The Board recommended a final dividend of ₹2.75 per share for shareholders.

Value
₹2,525 Cr
18:54 IST NSE
Management ChangeR K Swamy Ltd RKSWAMY

R K Swamy Management Change

R K SWAMY Limited appointed Ramesh Narayan as Independent Director for a three-year term. The Board also re-appointed M/s. ASA & Associates LLP as internal auditors.

Execution
3 years
18:53 IST NSE
AcquisitionFine Organic Industries Ltd FINEORG

Fine Organic Industries Acquisition Worth ₹82.86 Cr

Fine Organic Industries is acquiring an 80% stake in Oleofine Organics SDN. BHD. for ₹82.86 Crore. This strategic Malaysian expansion strengthens its specialty chemicals footprint.

Value
₹82.86 Cr
Execution
3 months
18:53 IST NSE
Financial ResultsAnthem Biosciences Ltd ANTHEM

Anthem Biosciences Q4 FY26 Results: Net Profit ₹189.8 Cr, Up 129.8% YoY

Anthem Biosciences Ltd reported revenue from operations of ₹610.9 Cr (+26.4% YoY) and net profit of ₹189.8 Cr (+129.8% YoY) for Q4 FY26.

Key figure
Net profit ₹189.8 Cr · +129.8% YoY
18:52 IST BSE
Debt & BorrowingHFCL Ltd HFCL

HFCL Debt & Borrowing: ₹265 Cr

HFCL Limited extended a ₹265 Crore corporate guarantee for its subsidiary, HTL Limited. This replaces a prior ₹295 Crore guarantee to support working capital requirements.

Value
₹265.0 Cr